ACTR No |
Recruitment Status |
Date Registered |
Start Date |
Description |
| ACTRN12607000452493 |
Open to recruitment |
10/09/2007 |
3/09/2007 |
The objective of the clinical trial is to compare findings achieved by traditional diagnostic procedures with those of the Medex Test in order
to define specificity and accuracy of the Medex Test device as a diagnostic tool for early Prostate Cancer detection. |
| ACTRN12607000450415 |
Not yet recruiting |
31/08/2007 |
1/09/2007 |
A Phase I Clinical Trial of a Christchurch Medical Research Foundation (CMRF)-56+ Blood Dendritic Cell Preparation for the Immunotherapy of
Metastatic Hormone Refractory Prostate Cancer
|
| ACTRN12607000335493 |
Open to recruitment |
22/06/2007 |
1/04/2007 |
Implantation of marker seeds into the prostate; to improve quality of radiotherapy delivery and to allow dose escalation for men with localised
prostate cancer
|
| ACTRN12607000263493 |
Open to recruitment |
16/05/2007 |
1/06/2007 |
Resistance and aerobic exercise for reducing treatment side-effects in men receiving androgen deprivation therapy (ADT) for prostate cancer
|
| ACTRN12607000082404 |
Not yet recruiting |
24/01/2007 |
1/04/2007 |
A pilot study to evaluate the feasibility, safety and tolerability of neoadjuvant triple therapy with zoledronic acid, docetaxel, and
luteinising hormone-releasing hormone (LH-RH) analogue for men with high-risk prostate cancer to be treated by radical prostatectomy |
| ACTRN12605000130662 |
Open to recruitment |
12/08/2005 |
15/12/2005 |
A phase 1 clinical trial of BDCA-BDC-01, a BDC-1 blood dendritic cell preparation loaded with control and tumour-associated antigens to evaluate the safety of
immune therapy in metastatic hormone refractory prostate cancer |
| ACTRN12605000538640 |
Open to recruitment |
28/09/2005 |
23/12/2003 |
Radiation sensitivity in prostate cancer patients |
| ACTRN12607000102471 |
Not yet recruiting |
31/01/2007 |
5/02/2007 |
A randomised study to investigate the effects of caudal lignocaine versus topical lignocaine on VAS pain scores in men undergoing trans-rectal
ultrasound guided biopsy of the prostate for the detection of prostate cancer |
| ACTRN12607000077460 |
Open to recruitment |
23/01/2007 |
1/07/2006 |
Prospective Study to investigate the ability of the GSTP1 methylation assay to assess response to chemotherapy in patients with metastatic
hormone-refractory prostate cancer |
| ACTRN12607000237482
|
Closed: follow-up continuing |
18/12/1995 |
24/06/1996 |
A randomised trial investigating the effectiveness of different durations of maximal androgen deprivation (using Zoladex and Eulexin) prior to
and during definitive radiation therapy for locally advanced carcinoma of the prostate to reduce the rate of local recurrence. |
| ACTRN12606000315516 |
Open to recruitment |
21/07/2006 |
17/07/2006 |
The Quality of Life Outcomes and the Pharmacokinetic and Pharmacodynamic Sequelae of Testosterone Undecanoate Injections compared with
Testosterone Implants for Androgen Replacement Therapy in men with Classical Male Hypogonadism |
| ACTRN12606000301561 |
Open to recruitment |
28/07/2004 |
1/08/2004 |
A collaborative randomised phase III trial: The timing Of intervention with Androgen Deprivation in prostate cancer patients with a rising
Prostate Specific Antigen (PSA)
|
| ACTRN12607000307404 |
Open to recruitment |
6/07/2005 |
6/07/2005 |
A randomised phase II study of PSA (prostate specific antigen) response and safety of two dose schedules of PI-88 in combination with docetaxel
in patients with androgen-independent prostate cancer |
| ACTRN12606000157572 |
Open to recruitment |
3/05/2006 |
27/04/2006 |
Prospective Outcomes-analysis for localised Prostate Adenocarcinoma after Radiotherapy Treatment, including external beam radiotherapy alone,
high dose rate brachytherapy in combination with external beam radiotherapy or seed implant brachytherapy |
| ACTRN12605000548639 |
Not yet recruiting |
29/09/2005 |
1/10/2005 |
THE EFFECT OF NITRATES ON PATIENTS WITH LOWER URINARY TRACT SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA |
| ACTRN12605000316606 |
Open to recruitment |
6/09/2005 |
5/05/2004 |
A Phase II study of Paclitaxel and Vinorelbine (PaclVin) in Hormone-refractory metastatic prostate cancer: Double Tubulin Targeting. The outcome measured is PSA
response |
|
|
CLOSED TRIALS
|
|
|
|
| ACTRN12607000097448 |
Closed: follow-up continuing |
23/12/2003 |
23/10/2003 |
A randomised trial investigating the effect on biomedical (Prostate Specific Antigen- PSA) control and survival of different durations of
adjuvant androgen (Leuprorelin acetate and zoledronic acid)deprivation in association with definite radiation treatment for localised carcinoma of the prostate (The RADAR trial)
|
| ACTRN12607000233426 |
Closed: follow-up continuing |
3/05/2007 |
1/11/2004 |
ProsCan: A long term outcomes study involving a trial of a supportive care intervention to improve psychosocial outcomes in patients with
Prostate Cancer.
|
| ACTRN12606000372583 |
Closed: follow-up continuing |
28/07/2004 |
1/02/2004 |
A feasibility and efficacy study, evaluating the prostate specific antigen (PSA) response, of taxotere/prednisone in combination with
thalidomide in hormone refractory prostate cancer |
| ACTRN12608000170325 |
Closed: follow-up complete |
8/04/2008 |
1/05/1999 |
A Phase II Study to Assess the Effect of Intermittent Androgen Blockade in the Treatment of Advanced Prostate Cancer |
| ACTRN12606000116527 |
Closed: follow-up continuing |
31/3/2006 |
12/03/2003 |
Randomised double-blind controlled trial of the use of daily sildenafil (Viagra) in men with early prostate cancer treated with radiation, for the prevention of
subsequent erectile dysfunction. |
